Post IPO investors in Europe
Updated 16 Nov 2026
Venture funds
7 funds, by portfolio companies funded in the last 12 months| # | Fund | Sectors | Stages | Leads | Funded, 12 months |
|---|---|---|---|---|---|
| 1 | Novo Holdings Novo Holdings invests in life science companies, with recent companies including Claris Biotherapeutics and Windward Bio. Hellerup, Denmark |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 36% | 5 |
| 2 | Triple Point Ventures London, United Kingdom |
Fintech, Artificial intelligence | Seed, Early stage venture, Late stage venture | 46% | 3 |
| 3 | Atlantic Bridge Atlantic Bridge is a European-headquartered growth equity technology fund, with recent investments in SweGaN and Selector. Dublin, Ireland |
Artificial intelligence, Hardware | Seed, Early stage venture, Late stage venture | 40% | 2 |
| 4 | Forbion Capital Partners Forbion Capital Partners makes private equity and venture capital investments in buyouts, with recent investments in Kynexis and Beacon Therapeutics. Naarden, The Netherlands |
Biotech, Health care | Seed, Early stage venture | 49% | 2 |
| 5 | Nextech Invest Nextech Invest is a venture capital and private equity firm spanning early to emerging growth stages, with recent companies Circle Pharma and Atavistik Bio. Zürich, Switzerland |
Health care, Biotech | Early stage venture, Late stage venture | 31% | 2 |
| 6 | Novartis Venture Fund Novartis Venture Fund focuses on novel therapeutics and platforms, with recent investments in Hepalink and FoRx Therapeutics. Basel, Switzerland |
Health care, Biotech | Seed, Early stage venture, Late stage venture | 27% | 2 |
| 7 | Seventure Partners Seventure Partners targets Tech/Digital and Life Sciences companies, with recent companies including Microbiotica and Standing Ovation. Paris, France |
Biotech, Health care | Seed, Early stage venture, Late stage venture | 36% | 2 |
Table 1. Post IPO investors in Europe: venture capital and micro VC funds ranked by companies whose most recent round closed in the last 12 months. Leads is the share of all recorded investments where the fund was lead investor. Source: FundingWatcher. Data as of 16 November 2026.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.
| Investor | Type | Location | Phone | |
|---|---|---|---|---|
| European Investment Bank | Investment bank | Luxembourg | •••@eib.org | +352 4••• |
| European Bank for Reconstruction and Development | Government investment office | London, United Kingdom | •••@ebrd.com | +44 20••• |
| Novo Holdings | Corporate venture arm | Hellerup, Denmark | •••@novo.dk | 45 35 ••• |
| Deutsche Bank | Investment bank | Frankfurt, Germany | •••@db.com | +49 69••• |
| Seventure Partners | Venture capital firm | Paris, France | •••@seventure.fr | +33 1-••• |
| Novartis Venture Fund | Corporate venture arm | Basel, Switzerland | •••@sosei.com | 877 28••• |
| HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | •••@hbmhealthcare.com | +41 41••• |
| Wellington Partners | Venture capital firm | Munich, Germany | •••@wellington-partners.com | +44 20••• |
8 rows of the CSV in 5 of its 15 columns, email and phone masked.
- 150 of the 242 post ipo investors in Europe have a published email address, 144 a phone number and 228 a website.
- European Investment Bank has the most recorded investments, 577, 486 of them as lead investor.
- 34 of them are investors in at least one company that closed its most recent round in the last 12 months.
- Novo Holdings is an investor in 5 of those companies, more than any other investor on this list.
- The newest round among their portfolio companies is ArtMaster's $2.4M seed round on 20 October 2026.
- Software is the most common sector across their 679 portfolio companies (61%).
- Early stage venture is the most common investment stage, recorded for 155 of them (64%).
Source: FundingWatcher. Data as of 16 November 2026. "Last 12 months" is the 365 days to that date.
Post IPO investors in Europe
30 of 242, most investments first| # | Investor | Type | Location | Invests in | Latest portfolio companies | Funded, 12 months | Investments | Lead | Exits | Phone | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | European Investment Bank | Investment bank, Private equity firm | Luxembourg | Artificial intelligence, Hardware | EnduroSat, NavVis, BIZAY | 4 | 577 | 486 | 188 | •••@eib.org | +352 4••• | In the CSV |
| 2 | European Bank for Reconstruction and Development | Government investment office, Investment bank | London, United Kingdom | Fintech | Hellas Direct, Param, Trafi | 456 | 355 | 107 | •••@ebrd.com | +44 20••• | In the CSV | |
| 3 | Novo Holdings | Corporate venture arm, Venture capital firm | Hellerup, Denmark | Health care, Biotech | Claris Biotherapeutics, Windward Bio, Terremoto Biosciences | 5 | 417 | 150 | 115 | •••@novo.dk | 45 35 ••• | In the CSV |
| 4 | Deutsche Bank | Investment bank | Frankfurt, Germany | Fintech, Artificial intelligence | Synthesized, Partior, Blueground | 304 | 102 | 132 | •••@db.com | +49 69••• | In the CSV | |
| 5 | Seventure Partners | Venture capital firm | Paris, France | Biotech, Health care | Microbiotica, Standing Ovation | 2 | 300 | 109 | 75 | •••@seventure.fr | +33 1-••• | In the CSV |
| 6 | Novartis Venture Fund | Corporate venture arm, Venture capital firm | Basel, Switzerland | Health care, Biotech | Hepalink, FoRx Therapeutics | 2 | 279 | 75 | 77 | •••@sosei.com | 877 28••• | |
| 7 | HBM Healthcare Investments | Venture capital firm | Zug, Switzerland | Biotech, Health care | 4TEEN4 Pharmaceuticals, Sphingotec GmbH, Odyssey Therapeutics | 260 | 47 | 90 | •••@hbmhealthcare.com | +41 41••• | ||
| 8 | Wellington Partners | Venture capital firm | Munich, Germany | Health care, Biotech | nyra health | 1 | 252 | 80 | 65 | •••@wellington-partners.com | +44 20••• | In the CSV |
| 9 | Janus Henderson Investors | Private equity firm, Venture capital firm | London, United Kingdom | Health care, Biotech | Claris Biotherapeutics | 1 | 240 | 34 | 144 | •••@janushenderson.com | +44 (0••• | In the CSV |
| 10 | FMO | Government investment office | The Hague, The Netherlands | Fintech, Commerce | dopay, YoLa Fresh, ftcash | 203 | 108 | 37 | •••@gmail.com | +31 70••• | In the CSV | |
| 11 | EQT Life Sciences | Private equity firm | Amsterdam, The Netherlands | Health care, Biotech | FoRx Therapeutics | 1 | 198 | 74 | 55 | •••@lspvc.com | +31 20••• | In the CSV |
| 12 | Abingworth | Private equity firm, Venture capital firm | London, United Kingdom | Biotech, Health care | Timberlyne Therapeutics, Myricx Bio, Anjarium Biosciences | 196 | 56 | 90 | •••@abingworth.com | (207) ••• | In the CSV | |
| 13 | Forbion Capital Partners | Private equity firm, Venture capital firm | Naarden, The Netherlands | Biotech, Health care | Kynexis, Beacon Therapeutics | 2 | 188 | 93 | 54 | •••@forbion.com | +31 35••• | In the CSV |
| 14 | Kinnevik | Venture capital firm | Stockholm, Sweden | Commerce, Artificial intelligence | Mews | 1 | 170 | 77 | 34 | •••@kinnevik.se | +46 (0••• | In the CSV |
| 15 | EXOR N.V. | Private equity firm | Amsterdam, The Netherlands | Artificial intelligence, Health care | Lupa Pets, Bee | 163 | 33 | 21 | •••@exor.com | 39-11-••• | In the CSV | |
| 16 | Auriga Partners | Micro VC fund, Venture capital firm | Paris, France | Hardware, Commerce | Patrowl, One More Company, Miliboo | 162 | 32 | 40 | •••@aurigapartners.com | In the CSV | ||
| 17 | UBS | Corporate venture arm, Fund of funds | Zürich, Switzerland | Fintech, Hardware | SWISSto12, MerQube, Nasdaq Private Market | 3 | 157 | 53 | 53 | •••@ubs.com | 41 44 ••• | In the CSV |
| 18 | Entrepreneur Venture | Venture capital firm | Paris, France | Artificial intelligence, Commerce | Mosh | 1 | 156 | 108 | 41 | •••@entrepreneurventure.com | +33 (0••• | In the CSV |
| 19 | Rocket Internet | Startup incubator, Private equity firm | Berlin, Germany | Fintech, Commerce | enshift | 1 | 155 | 43 | 52 | •••@rocket-internet.com | In the CSV | |
| 20 | Tikehau Capital | Private equity firm, Venture debt fund | Paris, France | Cybersecurity, Fintech | ChapsVision, Deskera, OSS Ventures | 151 | 121 | 71 | +65 67••• | In the CSV | ||
| 21 | Atlantic Bridge | Venture capital firm | Dublin, Ireland | Artificial intelligence, Hardware | SweGaN, Selector | 2 | 145 | 58 | 33 | •••@abven.com | +353 1••• | In the CSV |
| 22 | Pario Ventures | Startup accelerator | London, United Kingdom | Fintech, Commerce | Wrisk, Curve, GridDuck | 142 | 7 | 25 | •••@parioventures.com | In the CSV | ||
| 23 | BNP Paribas Développement | Private equity firm | Paris, France | Hardware, Cybersecurity | Sekoia, Dipeeo, ANOZR WAY | 139 | 20 | 26 | •••@bnpparibas.com | In the CSV | ||
| 24 | HealthCap | Venture capital firm | Stockholm, Sweden | Health care, Biotech | ADCendo | 1 | 132 | 33 | 37 | +46 8 ••• | In the CSV | |
| 25 | Kurma Partners | Venture capital firm | Paris, France | Health care, Biotech | Tacalyx | 1 | 131 | 65 | 18 | •••@kurmapartners.com | +33184••• | In the CSV |
| 26 | Ardian | Private equity firm | Paris, France | Hardware, Cybersecurity | Neotys, Sparus Software | 130 | 81 | 44 | •••@ardian.com | +33 1 ••• | In the CSV | |
| 27 | EQT | Private equity firm, Venture capital firm | Stockholm, Sweden | Fintech, Artificial intelligence | ArtMaster | 1 | 130 | 79 | 55 | •••@eqtpartners.com | +46 85••• | In the CSV |
| 28 | VI Partners | Venture capital firm | Altendorf, Switzerland | Health care, Biotech | L.E.S.S. | 1 | 111 | 26 | 22 | •••@vipartners.ch | +41 41••• | In the CSV |
| 29 | Credit Agricole CIB | Investment bank | Paris, France | Fintech, Cybersecurity | Ramify, Tenacy, Cobase | 108 | 15 | 50 | •••@ca-cib.com | In the CSV | ||
| 30 | CVC Capital Partners | Private equity firm | Luxembourg | Commerce, Fintech | Mellow, Reath, Bigstone Finance | 101 | 59 | 51 | •••@cvc.com | +352 2••• | In the CSV |
Table 2. Post IPO investors in Europe: the first 30 by recorded investments with a website and a location. Email and phone are masked here and complete in the CSV. Source: FundingWatcher. Data as of 16 November 2026. Base: 242.
Most active in the last 12 months
By portfolio companies funded| # | Investor | Location | Funded, 12 months | Portfolio | Latest |
|---|---|---|---|---|---|
| 1 | Novo Holdings | Hellerup, Denmark | 5 | 29 | Claris Biotherapeutics, Windward Bio, Terremoto Biosciences |
| 2 | European Investment Bank | Luxembourg | 4 | 23 | EnduroSat, NavVis, BIZAY |
| 3 | UBS | Zürich, Switzerland | 3 | 26 | SWISSto12, MerQube, Nasdaq Private Market |
| 4 | Triple Point Ventures | London, United Kingdom | 3 | 18 | Semble, Kohort, Veremark |
| 5 | Seventure Partners | Paris, France | 2 | 45 | Microbiotica, Standing Ovation |
| 6 | Nextech Invest | Zürich, Switzerland | 2 | 5 | Circle Pharma, Atavistik Bio |
| 7 | Forbion Capital Partners | Naarden, The Netherlands | 2 | 25 | Kynexis, Beacon Therapeutics |
| 8 | Atlantic Bridge | Dublin, Ireland | 2 | 26 | SweGaN, Selector |
| 9 | HSBC Innovation Banking | London, United Kingdom | 2 | 3 | Moss, Click Therapeutics |
| 10 | Novartis Venture Fund | Basel, Switzerland | 2 | 20 | Hepalink, FoRx Therapeutics |
| 11 | EQT | Stockholm, Sweden | 1 | 12 | ArtMaster |
| 12 | Marshall Wace | London, United Kingdom | 1 | 8 | TRM Labs |
| 13 | 3B Future Health Fund | Monaco, Germany | 1 | 2 | Navion Neurosciences |
| 14 | Ysios Capital | San Sebastian, Spain | 1 | 2 | Kynexis |
| 15 | BASF Venture Capital | Ludwigshafen, Germany | 1 | 8 | Computomics |
Table 3. Post IPO investors in Europe: investors in the most companies whose most recent round falls in the last 12 months. Source: FundingWatcher. Data as of 16 November 2026.
Latest rounds in their portfolios
Newest first| Company | What they do | Sector | Location | Last round | Amount | Date | Total raised | Investors on this list | Employees | Founded |
|---|---|---|---|---|---|---|---|---|---|---|
| ArtMaster | ArtMaster operates an online platform offering AI-powered music tutoring. | Artificial intelligence | Prague, Czech Republic | Seed | $2.4M | 2026-10-20 | $7.2M | EQT | 1 to 10 | 2018 |
| Microbiotica | Microbiotica develops live bacterial microbiome therapeutics and associated biomarkers. | Biotech | Cambridge, United Kingdom | Series C | $47.9M | 2026-10-16 | $130.7M | Seventure Partners | 11 to 50 | 2016 |
| EnduroSat | EnduroSat manufactures satellites and offers fixed-cost space services, having delivered over 200 satellites. | Artificial intelligence | Sofia, Bulgaria | Series C | $205.0M | 2026-09-16 | $385.8M | European Investment Bank | 251 to 500 | 2015 |
| Circle Pharma | Circle Pharma develops bioavailable macrocyclic peptide therapeutics that target protein-protein interactions. | Biotech | South San Francisco, United States | Series E | $92.5M | 2026-09-16 | $300.0M | Nextech Invest | 11 to 50 | 2012 |
| TRM Labs | TRM Labs provides blockchain analytics and transaction monitoring to financial institutions and governments. | Fintech | San Francisco, United States | Series C | $70.0M | 2026-09-09 | $219.9M | Marshall Wace | 251 to 500 | 2018 |
| Navion Neurosciences | Navion Neurosciences develops sodium channel therapeutics for neurological diseases at a pre-clinical stage. | Artificial intelligence | Charlottesville, United States | Seed | $10.8M | 2026-09-09 | $21.2M | 3B Future Health Fund | 1 to 10 | 2021 |
| Kynexis | Kynexis develops precision medicine treatments for cognitive impairment associated with schizophrenia. | Biotech | Naarden, The Netherlands | Series A | $112.3M | 2026-08-19 | $173.3M | Ysios Capital, Forbion Capital Partners | 11 to 50 | 2023 |
| Computomics | Computomics applies artificial intelligence to genomics data to advance agricultural solutions. | Artificial intelligence | Tübingen, Germany | Series B | $7.3M | 2026-08-18 | $10.0M | BASF Venture Capital | 11 to 50 | 2012 |
| SweGaN | SweGaN provides GaN-on-SiC epiwafers for RF component manufacturers. | Hardware | Linköping, Sweden | Series B | $14.0M | 2026-08-17 | $39.7M | Atlantic Bridge | 11 to 50 | 2014 |
| NavVis | NavVis captures and shares the built environment as photorealistic digital twins. | Hardware | Munich, Germany | Series D | $85.0M | 2026-08-06 | $181.4M | European Investment Bank | 251 to 500 | 2013 |
Table 4. Post IPO investors in Europe: the 10 most recent rounds of companies they back. Source: FundingWatcher. Data as of 16 November 2026.
Portfolio sectors
| Portfolio sectors | Companies | Share |
|---|---|---|
| Software | 413 | 61% |
| Health care | 172 | 25% |
| Biotech | 145 | 21% |
| Fintech | 124 | 18% |
| Artificial intelligence | 113 | 17% |
| Hardware | 102 | 15% |
| Commerce | 58 | 9% |
| Cybersecurity | 36 | 5% |
| Energy | 19 | 3% |
| Education | 16 | 2% |
Table 5. Post IPO investors in Europe: portfolio companies by sector. Source: FundingWatcher. Data as of 16 November 2026.
Investment stages
| Investment stages | Investors | Share |
|---|---|---|
| Post IPO investors | 242 | 100% |
| Early stage investors | 155 | 64% |
| Private equity investors | 135 | 56% |
| Venture investors | 132 | 55% |
| Late stage investors | 127 | 52% |
| Seed investors | 103 | 43% |
| Debt investors | 86 | 36% |
| Secondary market investors | 52 | 21% |
Table 6. Post IPO investors in Europe by stage they invest at. Source: FundingWatcher. Data as of 16 November 2026.
Countries
| Countries | Investors | Share |
|---|---|---|
| United Kingdom | 84 | 35% |
| Switzerland | 26 | 11% |
| Germany | 25 | 10% |
| Sweden | 24 | 10% |
| France | 22 | 9% |
| The Netherlands | 13 | 5% |
| Spain | 9 | 4% |
| Luxembourg | 7 | 3% |
| Italy | 7 | 3% |
| Belgium | 4 | 2% |
| Denmark | 3 | 1% |
| Ireland | 3 | 1% |
Table 7. Post IPO investors in Europe by headquarters country. Source: FundingWatcher. Data as of 16 November 2026.
Cities
Table 8. Post IPO investors in Europe by headquarters city. Source: FundingWatcher. Data as of 16 November 2026.
Founded
| Founded | Investors | Share |
|---|---|---|
| 2020s | 18 | 9% |
| 2010s | 66 | 32% |
| 2000s | 54 | 26% |
| 1990s | 25 | 12% |
| 1980s | 13 | 6% |
| 1970s | 4 | 2% |
Table 9. Post IPO investors in Europe by founding decade. Source: FundingWatcher. Data as of 16 November 2026.
Method
- An investor is on this list when its recorded investment stages include post ipo investors and its headquarters is in Europe. On 16 November 2026 that is 242 investors.
- 150 rows carry an email address and 144 a phone number from the investor file. Investments, lead investments and exits are the counts the source records.
- The table prints the first 30 rows by recorded investments that carry a website and a location, with email and phone masked. The CSV carries all 242 rows: 14 have no website and 0 no location.
Sources, fields and exclusions of both files: Method.
Questions
- How many post ipo investors in Europe are on the list?
- 242, in the file dated 16 November 2026. 34 of them invested in a company whose most recent round falls in the last 12 months.
- How many have an email address?
- 150 of the 242 carry an email address in the download and 144 a phone number.
- What does the CSV contain?
- One row per investor, 15 columns: name, types, stages, city, region, country, founded, website, linkedin, investments, funded_last_12m, exits, lead_investments, email, phone.
- How much does the list cost?
- $29 one-time for all 242 rows, no account. Every investor and every startup, two files, cost $99. With partner contacts, up to 2 per firm compiled to order and mailed within 24 hours, $199.
- What arrives after payment?
- At once: the CSV with 242 rows, 150 firm email addresses and 144 phone numbers, on the page after payment and by mail. The emails are the address a firm publishes: 101 of the 150 are inboxes such as info@ or contact@. No partner names.
- Can I see rows before buying?
- The 3 rows under the buy button are rows of the CSV with every column. The form below it mails 10 rows.
- How current is the data?
- The file is dated 16 November 2026. The download link serves the current file each time it is opened.
Not sure about the data?
Download a free 10-row sample first. No account, no payment.